Preclinical Validation Of First In Man Endovascular Brain Machine Interface Device

Grant number: 1138110 | Funding period: 2018 - 2020



The stentrode technology has been given significant public attention, following publication in the fourth highest impact factor journal 'Nature Biotechnology' and a public statement of endorsement by the President of the United States in 2016. The program now seeks to conduct a preclinical validation program to satisfy the FDA in its requirements to provide Investigational Device Exemption (IDE).